Injectable GHK-Cu -- Systemic Goals Community-reported use cases for injectable GHK-Cu include: Systemic tissue repair -- community protocols describe subcutaneous injection for generalized healing support, particularly post-injury Joint and connective tissue -- animal models document connective-tissue effects
I think there are 2 different issues here :- 1) People in U.K
Targeted, short-term support
44-46 High blood glucose levels trigger the production of large amounts of advanced glycation end-products (AGEs), proteins and lipids damaged by spontaneous reactions with glucose
The downstream effects include: Synaptogenesis : Formation of new synaptic connections in hippocampal neurons, driven by c-Met-mediated activation of PI3K/AKT and MAPK/ERK signaling cascades Spinogenesis : Growth of new dendritic spines, the structural substrate for excitatory synaptic transmission Neurotrophic support : In cell-based neurotrophic assays, Dihexa demonstrated potency approximately seven orders of magnitude greater than BDNF The HGF/c-Met pathway is distinct from the BDNF/TrkB and NGF/TrkA pathways targeted by most nootropic peptides
The injection depth, technique, and concentration of growth factors are adjusted accordingly